movement disorders
TRANSCRIPT
![Page 1: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/1.jpg)
Movement Movement DisordersDisorders
Parkinson’sParkinson’s
EpilepsyEpilepsy
![Page 2: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/2.jpg)
Parkinson’sParkinson’s
• DefinitionsDefinitions– TremorTremor– ChoreaChorea– AthetosisAthetosis– DystoniaDystonia– TicsTics
• Signs & SymptomsSigns & Symptoms– Mask facies/droolMask facies/drool– Scuffle gaitScuffle gait– Tremor/rigidityTremor/rigidity– Pill rollingPill rolling– BradykinesiaBradykinesia– Postural instability Postural instability
with increasing with increasing disabilitydisability
– www.parkinson.orgwww.parkinson.org
![Page 3: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/3.jpg)
The Parkinson Balancing The Parkinson Balancing ActAct
Normal Balance
Parkinson’s Disease
Drug Therapy in Parkinson’s
![Page 4: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/4.jpg)
Metabolism of LevodopaMetabolism of Levodopa
Levodopa
3,O-MethyldopaDopamine
Degradation products
![Page 5: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/5.jpg)
Treatment of Parkinson’sTreatment of Parkinson’s
Drug ActionDrug Action AgentsAgents
Increase DAIncrease DA
Stimulate DA Stimulate DA receptorsreceptors
Levodopa-carbidopa Levodopa-carbidopa (Sinemet)(Sinemet)
Bromocriptine, Bromocriptine, Pergolide(Permax) Pergolide(Permax) Pramipexole(Mirapex), Pramipexole(Mirapex), Ropinirole(Requip)Ropinirole(Requip)
Inhibit DA Inhibit DA MetabolismMetabolism
Selegiline(Eldepryl), Selegiline(Eldepryl), Tolcapone (Tasmar), Tolcapone (Tasmar), Entacapone (Comtan)Entacapone (Comtan)
Increase DA & inhibit Increase DA & inhibit metabolismmetabolism
Carbidopa-levodopa/Carbidopa-levodopa/entacapone (Stalevo)entacapone (Stalevo)
MiscellaneousMiscellaneous Amantadine, benztropin, Amantadine, benztropin, diphenhydramine, diphenhydramine, trihexyphenidyltrihexyphenidyl
![Page 6: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/6.jpg)
Drug TherapyDrug Therapy
• Levodopa Levodopa • Carbidopa/Carbidopa/
Levodopa (Sinemet)Levodopa (Sinemet)– MOAMOA– ToxicityToxicity– Response Response
fluctuationsfluctuations– Drug HolidayDrug Holiday– On/Off PhenomenonOn/Off Phenomenon– Drug InteractionsDrug Interactions
• Dopamine AgonistsDopamine Agonists• Bromocriptine Bromocriptine
(Parlodel)(Parlodel)• Pergolide (Permax)Pergolide (Permax)
– MOAMOA– ToxicityToxicity
• Non-ergot DA AgonistNon-ergot DA Agonist– Pramipexole (MIrapex)Pramipexole (MIrapex)
• AmantadineAmantadine– AntiviralAntiviral
![Page 7: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/7.jpg)
Clinical ManagementClinical Management
• Progressive disease- Benefits of drug Progressive disease- Benefits of drug therapy decrease over timetherapy decrease over time
• Alleviate symptomsAlleviate symptoms• Stepped care treatmentStepped care treatment
– Drug treatmentDrug treatment– Physical TherapyPhysical Therapy– Reduce protein in dietReduce protein in diet– SurgerySurgery
![Page 8: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/8.jpg)
Case Study Parkinson’sCase Study Parkinson’s
![Page 9: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/9.jpg)
M.G. is a 56-year-old female who presented to clinic M.G. is a 56-year-old female who presented to clinic with complaints of anxiety, nervousness, weakness of with complaints of anxiety, nervousness, weakness of the right hand and tremors. She has a history of the right hand and tremors. She has a history of hypertension that has been untreated. At the time of hypertension that has been untreated. At the time of her initial visit, she was given Diazepam 2 mg TID. It her initial visit, she was given Diazepam 2 mg TID. It helped her nervousness, but it did not help her helped her nervousness, but it did not help her tremors. Two months later she returns to clinic. Her tremors. Two months later she returns to clinic. Her complaints are the same. She feels they are complaints are the same. She feels they are worsened by stressful situations. Many of the worsened by stressful situations. Many of the symptoms were initially noted at the time of her symptoms were initially noted at the time of her husband’s death six months ago. Her friends have husband’s death six months ago. Her friends have told her that her voice is changing. On physical told her that her voice is changing. On physical examination the patient appears well nourished in no examination the patient appears well nourished in no acute distress. She has noticeable tremors in both acute distress. She has noticeable tremors in both hands and cogwheel rigidity of both arms. There is hands and cogwheel rigidity of both arms. There is slight mask-like facies. Labs within normal limits slight mask-like facies. Labs within normal limits except borderline glucose.except borderline glucose.
• BP recline 200/112 Fam HX non-contributoryBP recline 200/112 Fam HX non-contributory• Sitting 202/105 PE non-contributorySitting 202/105 PE non-contributory
![Page 10: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/10.jpg)
Points to PonderPoints to Ponder
• Symptoms present for Parkinson’s.Symptoms present for Parkinson’s.• Possible medications that may Possible medications that may
worsen symptoms.worsen symptoms.• What medications should be used to What medications should be used to
treat her symptoms?treat her symptoms?• Comment on her blood pressure.Comment on her blood pressure.• Comment on her psychological Comment on her psychological
problems..problems..
![Page 11: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/11.jpg)
Epilepsy
• Anatomy of a seizure• Pharmacology
• Prevent spread of seizure• Depress motor cortex• Raise seizure threshold• Alter levels of NE• Depress neural discharge
![Page 12: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/12.jpg)
Overview of Triggers
• Genetic Factors• Brain lesion at
birth
• Toxins• Alcohol• Drugs/ Poisons
• Cerebral Vascular• Stroke, TIA• Malformations
• Trauma• Infections
• High fever
• Metabolic Disorders• Low Ca++/Na++• Hypoxia (02)• Glucose (hyper/
hypo)
• Neoplasm
![Page 13: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/13.jpg)
Clinical Management of Epilepsy
• Partial seizure & Tonic/Clonic• Generalized• Infantile • Status Epilepticus
• Life threatening
• Withdrawal• Overdose
![Page 14: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/14.jpg)
Seizure Type by Incidence
10%23%
65%
![Page 15: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/15.jpg)
MOA of Anticonvulsants
• Pharmacology • Prevent spread of
seizure• Depress motor
cortex• Raise seizure
threshold• Alter levels of NE• Depress neural
discharge
• Methods• Blocks Na+
channels• Blocks Ca+
channels• GABA agonist• Glutamate blocker
![Page 16: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/16.jpg)
![Page 17: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/17.jpg)
Pharmacologic Agents
• Phenytoin* (Dilantin)• Fetal Hydantoin
• Carbamazepine * (Tegretol)
• Phenobarbitol *• Primidone* (Mysoline)• Lamotrigine (Lamictal)
• Gabapentin (Neurontin)• Topiramate (Topamox)• Ethosuximide
(Zarontin)• Valproic Acid• Sodium Valproate
(Depakene)
![Page 18: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/18.jpg)
Management of Epilepsy
• Problems• Medication Control
• Side effects• Dosing regimens
• Compliance• Education• Medical Factors• Psychosocial
Factors
• Strategies• Patients can
• Keep informed & diary
• Support group• Reminder systems
• Family can• Minimize barriers• Encouragement
![Page 19: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/19.jpg)
Case StudyEpilepsy
![Page 20: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/20.jpg)
• J.F. is a 44-year-old male who was seen in the clinic complaining of weakness in his right hand, tremors, and nervousness. Not much was thought of this until his return three months later. J.F. now appears depressed with an expressionless face and voice. He has a persistent tremor, blurred vision and difficulty moving. Occasional angina attacks bother him, which are relieved by NTG sublingual tablets. During the visit he becomes increasingly agitated and the physician prescribes Valium 5 mg one dose. As you are talking to him he suddenly falls to the ground and has a grand mal seizure.
• PMH : HTN x10 yr. Glaucoma x3yr Angina x5yr AODM x7yr• PE: BP 185/110 supine tremors in both hands• 182/100 sitting cogwheel rigidity in both arms• Meds Micronase 5 mg bid HCTZ 50mg QD Lotensin 20mg
BID• Nitroquick 0.4mg Betagan 0.5% 1 gtt bid
• Labs Hct 45.3 Na 140 K 3.9 Cl 102 WBC 8.3 BUN 18• Hgb 15.2 Cr 1.0 Gluc 220 Uric Acid 9.5
![Page 21: Movement disorders](https://reader036.vdocument.in/reader036/viewer/2022070319/557cea03d8b42ae6078b4c27/html5/thumbnails/21.jpg)
Points to Ponder
• List symptoms that are of concern.
• List PE and labs that are of concern.
• What are the possible etiologies?• Comment on patient medication
list.• List a possible treatment plan.